ロード中...
A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma
BACKGROUND: To date only a handful of drugs are available for the treatment of melanoma. Among them vemurafenib, a Braf(V600E) specific inhibitor, showed promising results in terms of response rate and increase in median survival time. However, its effectiveness is limited by development of resistan...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4051389/ https://ncbi.nlm.nih.gov/pubmed/24893747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-398 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|